HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): John A. Hawkins Lloyd Y. Tani Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Askovich, B. Articles by Puchalski, M. D. Search for Related Content PubMed PubMed Citation Articles by Askovich, B. Articles by Puchalski, M. D. Related Collections Congenital - cyanotic

Ann Thorac Surg 2007;84:907-912
© 2007 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Right Ventricle–to–Pulmonary Artery Conduit Longevity: Is it Related to Allograft Size?

^a Department of Pediatrics, University of Utah and Primary Children’s Medical Center, Salt Lake City, Utah
^b Department of Surgery, University of Utah and Primary Children’s Medical Center, Salt Lake City, Utah
^c Department of Internal Medicine, University of Utah, Salt Lake City, Utah

Accepted for publication April 24, 2007.

^_* Address correspondence to Dr Puchalski, Primary Children’s Medical Center, 100 N Medical Dr, Salt Lake City, UT 84113 (Email: michael.puchalski{at}intermountainmail.org).

Presented at the Forty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 29–31, 2007.

Background: Cryopreserved valved allografts are routinely oversized to account for somatic growth in children requiring right ventricle–to–pulmonary artery (RV-PA) continuity. The objective of this study is to determine the effect of oversizing on conduit longevity.

Methods: We reviewed the records of all patients undergoing RV-PA cryopreserved valved allograft placement from 1988 to 2006 for diagnosis, age, allograft type, time to valved conduit explant, and indication for surgery. Conduit size at the time of insertion was compared with pulmonary valve size normalized for body surface area (z score). Multivariate Cox regression models with cluster analysis were constructed to assess risk of allograft oversizing for conduit failure. Kaplan-Meier analysis was used to obtain median freedom from explantation time.

Results: A total of 140 cryopreserved valved allografts (z score, 1.8 ± 1.3; range, –1.5 to 4.9) were implanted in 99 patients (median age, 5.6 years). Reoperation was required in 66 (67%) of 99 patients during the study period. Modeling z scores as a dichotomous variable revealed that risk of allograft explantation increases 113% when allografts with z scores of 2.7 or higher are used compared with those with z scores of less than 2.7 (p < 0.01). Median adjusted freedom from explantation for this same grouping was 4.9 years versus 9.4 years. The presence of branch pulmonary artery stenosis shortens the conduit life (p < 0.001), whereas insertion of a pulmonary allograft may extend the conduit life (p = 0.13).

Conclusions: Cryopreserved valved allograft oversizing (z score 2.7) in the pulmonary position results in decreased longevity in children. Presence of branch pulmonary artery stenosis is also associated with earlier conduit explantation.

This article has been cited by other articles:

				P. Lurz, L. Coats, S. Khambadkone, J. Nordmeyer, Y. Boudjemline, S. Schievano, V. Muthurangu, T. Y. Lee, G. Parenzan, G. Derrick, et al. Percutaneous Pulmonary Valve Implantation: Impact of Evolving Technology and Learning Curve on Clinical Outcome Circulation, April 15, 2008; 117(15): 1964 - 1972. [Abstract] [Full Text] [PDF]